WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SELECT * FROM wp_clean_up_optimizer_ip_locations WHERE ip=''

WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SHOW FULL COLUMNS FROM `wp_clean_up_optimizer_ip_locations`

Roadman Investments Applauds the City of Chicago’s Decriminalization of Entheogenic Plants – Shroom Investor 🍄

VANCOUVER, British Columbia, Oct. 21, 2019 — Roadman Investments Corp. (LITT.V)(FWB:1QD)(OTC:RMANF) (“Roadman Investments” or the “Company”) applauds the city of Chicago’s resolution that allows for plant-based hallucinogenic practices and ends the investigation and imposition of criminal penalties for use and possession of hallucinogens derived from plants or fungi, such as mushrooms, cactuses and the iboga plant. The resolution supports Entheogenic Plant practices and declares that the investigation and arrest of individuals involved with the adult use of Entheogenic Plants on the Federal Schedule 1 List be amongst the lowest priority for the Chicago Police Department.

The resolution was passed with a unanimous 50-0 vote making Chicago the third city in the US to decriminalize entheogenic plants.  Chicago’s effort follows in the footsteps of Denver and Oakland, two other large US cities which passed similar measures earlier this year. At nearly 10 million people, Chicago’s metropolitan area is the third most populous in the US making this a major milestone for the North American Wide effort to decriminalize psychedelics.  

Psilocybin, naturally occurring in Entheogenic mushrooms, has been studied extensively in recent years and data shows that it can alleviate end-of-life anxiety for hospice and terminal cancer patients, can reduce prison recidivism, can effectively treat substance abuse, anxiety and depression. With growing positive scientific findings and a mental health crisis more cities are reviewing similar initiatives as the wave of decriminalization garners momentum. Roadman Investments is actively evaluating investments in companies developing treatments utilizing entheogenic plants.

  Subscribe to news from
Right Season Investments

Be the first to know when breaking news are released.

CEO and Director Luke Montaine commented: “There is an immense policy shift that is just beginning and the positive news coming from Chicago are just the start. Psychedelic treatments are proven to be effective and our company is looking forward to investing in the leading companies in this industry.”

The full resolution can be accessed here.

About Roadman Investments
Roadman Investments is mandated with realizing alpha returns for its shareholders via the tactical deployment of capital across the resource, agricultural, financial services, technology and health and wellness verticals.

For further information, please contact:

Media Contact:
Nikolai Vassev
+1 (778) 772-1751

Learn more about Roadman by visiting our website at: https://roadmancorp.com/

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements – This news release contains certain forward-looking statements, including statements regarding the business of the Company. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward looking statements, oral or written, made by itself or on its behalf except as required by law.